Guideline for Constipation Management in Gastrostomy‑Tube Patients

First‑Line Therapy

Polyethylene glycol (PEG/macrogol) is the preferred first‑line laxative for patients receiving nutrition via a gastrostomy tube because it effectively hydrates stool, is not metabolized, preserves bowel pH and flora, and can be administered safely through the tube without causing obstruction. 1
The recommended PEG dosing for tube‑fed patients is one capful mixed with 240 mL of water, given twice daily; adequate fluid intake can be reliably provided through the gastrostomy tube. 2

Lactulose (30–60 mL 2–4 times daily) is effective but frequently produces flatulence, bloating, and abdominal cramping, making it less desirable than PEG. 1, 2
Sorbitol (30 mL every 2 hours for three doses, then PRN) can be used but may cause diarrhea, especially when present in liquid medication formulations. 2, 3
Magnesium hydroxide (30–60 mL daily to twice daily) or magnesium citrate (240 mL daily) are viable options, but must be used cautiously in patients with renal impairment because of the risk of hypermagnesemia. 1, 2

Bisacodyl (10–15 mg once daily to three times daily) can be employed with the goal of achieving one non‑forced bowel movement every 1–2 days. 2
Senna (2–3 tablets 2–3 times daily) is safe and effective, including in pregnant or lactating patients. 1

Flush the tube with at least 30 mL of water immediately before giving any laxative to prevent obstruction. 3
Administer each medication separately; do not mix laxatives with other drugs to avoid interaction risks. 3
Flush the tube with at least 30 mL of water after medication delivery to ensure complete passage and reduce blockage risk. 3

Bulk‑forming agents (e.g., psyllium, ispaghula) are not recommended because they require large fluid volumes that may be unattainable and they pose a risk of tube obstruction; they are also contraindicated for opioid‑induced constipation. 1

Aim for one non‑forced bowel movement every 1–2 days. 2
Begin with standard dosing and titrate upward to achieve maximal benefit while maintaining tolerance. 2
Continuously assess constipation symptom control and reduction of patient/family distress. 2

If constipation persists, first exclude fecal impaction by digital rectal examination; when impaction is present, suppositories or enemas become first‑line therapy. 1, 2
Consider adding a prokinetic agent such as metoclopramide 10–20 mg orally four times daily when standard laxatives are insufficient. 2
For opioid‑induced constipation, peripheral opioid antagonists (e.g., methylnaltrexone 0.15 mg/kg subcutaneously every other day) are recommended. 1, 2

Keep patients positioned at an angle of ≥30° during and for at least 30 minutes after feeding to lower aspiration risk. 7
In continuous feeding regimens, schedule feeding breaks of 4–8 hours to allow gastric pH to fall and reduce bacterial overgrowth. 7
Monitor gastric residual volumes every 4 hours; if volumes exceed 200 mL, reassess the feeding protocol. 7

Do not attribute new‑onset diarrhea to laxatives without first ruling out other causes such as recent antibiotic use. 7
Monitor electrolytes (sodium, potassium, magnesium, calcium, phosphate) closely when initiating any laxative regimen, especially in malnourished individuals. 7